Start Your Risk-Free Trial

Cefaclor — Discount Pricing

Cefaclor is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.

Cefaclor Pricing

Pricing typePrice
TheDrugClubDiscount pricing may be available
Typical Retail$74.00

Discount pricing may be available; confirm the price with the dispensing pharmacy.

About Cefaclor

Cefaclor is a prescription medication. Ask your doctor if Cefaclor is right for you.

How to Check Cefaclor Pricing

  1. Join TheDrugClub for $19.95/month
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available discount pricing

Cefaclor at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

Other medications in Infections

What Cefaclor is approved for (FDA label)

Cefaclor is indicated in the treatment of the following infections when caused by susceptible strains of the designated microorganisms: Otitis media caused by Streptococcus pneumoniae, Haemophilus influenzae, staphylococci, and Streptococcus pyogenes Note: β-lactamase-negative, ampicillin-resistant (BLNAR) strains of Haemophilus influenzae should be considered resistant to cefaclor despite apparent in vitro susceptibility of some BLNAR strains. Lower respiratory tract infections, including pneumonia, caused by Streptococcus pneumoniae, Haemophilus influenzae, and Streptococcus pyogenes Note: β-lactamase-negative, ampicillin-resistant (BLNAR) strains of Haemophilus influenzae should be considered resistant to cefaclor despite apparent in vitro susceptibility of some BLNAR strains.

Source: Read the full FDA label on DailyMed. Label effective date: May 1, 2025.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Cefaclor (FDA label)

Adverse effects considered to be related to therapy with cefaclor are listed below: Hypersensitivity reactions have been reported in about 1.5% of patients and include morbilliform eruptions (1 in 100). Pruritus, urticaria, and positive Coombs' tests each occur in less than 1 in 200 patients. Cases of serum-sickness-like reactions have been reported with the use of cefaclor. These are characterized by findings of erythema multiforme, rashes, and other skin manifestations accompanied by arthritis/arthralgia, with or without fever, and differ from classic serum sickness in that there is infrequently associated lymphadenopathy and proteinuria, no circulating immune complexes, and no evidence to date of sequelae of the reaction. Occasionally, solitary symptoms may occur, but do not represent a serum-sickness-like reaction.

Source: FDA prescribing information (DailyMed). Set ID: 2f61354e-bcb0-41aa-955f-51eabc11387b. SPL document ID: 3417e20b-604b-3cdd-e063-6394a90ac707. Label effective date: May 1, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Cefaclor (FDA label)

Cefaclor is contraindicated in patients with known allergy to the cephalosporin group of antibiotics.

Source: FDA prescribing information (DailyMed). Set ID: 2f61354e-bcb0-41aa-955f-51eabc11387b. SPL document ID: 3417e20b-604b-3cdd-e063-6394a90ac707. Label effective date: May 1, 2025. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial
Start Your Risk-Free Trial